OBJECTIVES: Between April and September of 2009 we evaluated the accuracy of the OraQuick HCV rapid antibody test and assessed its feasibility for use by community-based organizations (CBOs) serving populations at high risk for HCV in New York City. METHODS: We compared the results of screening by OraQuick (oral swab) and enzyme immunoassay (EIA; blood draw). We performed ribonucleic acid polymerase chain reaction testing for discordant results. We also assessed research staff perceptions through a survey and focus group. RESULTS: Overall, 97.5% of OraQuick and EIA results matched. Testing of discordant samples indicated that the rapid test was more likely than the EIA to provide a correct diagnosis. Research staff preferred the rapid test and identified challenges that would be overcome with its use. CBOs could benefit from increased testing capacity, and clients might benefit from more rapid access to education, counseling, and referrals. CONCLUSIONS: OraQuick's accuracy is comparable to the EIA. The oral swab rapid test could help HCV screening programs reach individuals unaware of their status and expand testing into nonclinical settings such as mobile units.
OBJECTIVES: Between April and September of 2009 we evaluated the accuracy of the OraQuick HCV rapid antibody test and assessed its feasibility for use by community-based organizations (CBOs) serving populations at high risk for HCV in New York City. METHODS: We compared the results of screening by OraQuick (oral swab) and enzyme immunoassay (EIA; blood draw). We performed ribonucleic acid polymerase chain reaction testing for discordant results. We also assessed research staff perceptions through a survey and focus group. RESULTS: Overall, 97.5% of OraQuick and EIA results matched. Testing of discordant samples indicated that the rapid test was more likely than the EIA to provide a correct diagnosis. Research staff preferred the rapid test and identified challenges that would be overcome with its use. CBOs could benefit from increased testing capacity, and clients might benefit from more rapid access to education, counseling, and referrals. CONCLUSIONS: OraQuick's accuracy is comparable to the EIA. The oral swab rapid test could help HCV screening programs reach individuals unaware of their status and expand testing into nonclinical settings such as mobile units.
Authors: Stephen R Lee; Keith W Kardos; Eugene Schiff; Cheryl A Berne; Karam Mounzer; Alpha T Banks; Harvey A Tatum; Timothy J Friel; Michael P Demicco; William M Lee; Scott E Eder; Alexander Monto; Graham D Yearwood; Geraldine B Guillon; Lisa A Kurtz; Mark Fischl; Jay Lynn Unangst; Laura Kriebel; Gary Feiss; Michele Roehler Journal: J Virol Methods Date: 2010-12-21 Impact factor: 2.014
Authors: Thomas S Liang; Emily Erbelding; Claude A Jacob; Howard Wicker; Carol Christmyer; Sterling Brunson; Damaris Richardson; Jonathan M Ellen Journal: AIDS Patient Care STDS Date: 2005-04 Impact factor: 5.078
Authors: Mara San Antonio-Gaddy; April Richardson-Moore; Gale R Burstein; Daniel R Newman; Bernard M Branson; Guthrie S Birkhead Journal: J Acquir Immune Defic Syndr Date: 2006-12-01 Impact factor: 3.731
Authors: Holly Hagan; Jennifer Campbell; Hanne Thiede; Steffanie Strathdee; Lawrence Ouellet; Farzana Kapadia; Sharon Hudson; Richard S Garfein Journal: Public Health Rep Date: 2006 Nov-Dec Impact factor: 2.792
Authors: Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter Journal: Ann Intern Med Date: 2006-05-16 Impact factor: 25.391
Authors: Mardge H Cohen; Dennis Grey; Judith A Cook; Kathryn Anastos; Eric Seaberg; Michael Augenbraun; Pam Burian; Marion Peters; Mary Young; Audrey French Journal: J Gen Intern Med Date: 2007-10-09 Impact factor: 5.128
Authors: Mitchell L Shiffman; Fredy Suter; Bruce R Bacon; David Nelson; Hugh Harley; Ricard Solá; Stephen D Shafran; Karl Barange; Amy Lin; Ash Soman; Stefan Zeuzem Journal: N Engl J Med Date: 2007-07-12 Impact factor: 91.245
Authors: Janice M Yoshizawa; Christopher A Schafer; Jason J Schafer; James J Farrell; Bruce J Paster; David T W Wong Journal: Clin Microbiol Rev Date: 2013-10 Impact factor: 26.132
Authors: Robert P Myers; Pam Crotty; Susanna Town; Janine English; Kevin Fonseca; Raymond Tellier; Mark G Swain; S Elizabeth McGregor; Steven J Heitman; Robert J Hilsden Journal: CMAJ Open Date: 2015-01-13